Perfil de mem?ria e ativa??o de linf?citos T na leishmaniose visceral

• Main Author: Rodrigues Neto, Jo?o Firmino
• Other Authors: CPF:05825113568
• Format: Others
• Language: Portuguese
• Published: Universidade Federal do Rio Grande do Norte 2014
• Subjects: Resposta imune; Ativa??o celular; Mem?ria imunol?gica; Leishmaniose visceral; Immune response; Cellular activation; Immune memory; Visceral leishmaniasis; CNPQ::CIENCIAS BIOLOGICAS::BIOQUIMICA
• Online Access: http://repositorio.ufrn.br:8080/jspui/handle/123456789/12574

Made available in DSpace on 2014-12-17T14:03:36Z (GMT). No. of bitstreams: 1 JoaoFRN_DISSERT.pdf: 3516278 bytes, checksum: 9fe0338a2547517c2f45d91b7860116c (MD5) Previous issue date: 2010-12-03 === Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior === Visceral leishmaniasis (VL) in Brazil is a disease caused by Leishmania infantum chagasi (L.i.chagasi). The clinical evolution post-infection depends on the vertebrate host immune response, which is genetically mediated. This study aimed to evaluate the immune response of individuals living in endemic area for VL in the state of the Rio Grande do Norte, considering individuals with VL under treatment (n = 9), recovered VL <1 year post treatment (n = 10), > 10 years posttreatment (n = 9), uninfected individuals living in endemic areas (n = 7), individuals that lost DTH response (n=6) and asymptomatic individuals for VL (n=9). Peripheral blood cells were evaluated in the presence and absence of soluble Leishmania antigens (SLA) and ex vivo, to determine activation, presence of regulatory cells and memory cells. The Leishmania parasitemia and anti-Leishmania antibodies were determined respectively by qPCR and ELISA. Cells from individuals with VL under treatment showed less cell activation after stimulation with SLA for the markers CD4/CD69, CD8/CD69 and CD8/CD25 compared with VL post treatment treatment (p <0.001). Apparently uninfected individuals have a higher cell activation than symptomatic VL (p <0.001), with the exception of CD8/CD25 marker (p = 0.6662). On the other hand, in the ex-vivo group, significant differences were observed for CD4/CD69, CD8/CD69 and CD8/CD25 between the 4 groups due to increased cell activation present in cells of individuals symptomatic LV (p <0.001). VL cells under treatment, ex vivo, have a lower percentage of memory cells (CD4/CD45RO and CD8/CD45RO) than individuals VL post-treatment or control group (p = <0.01). Likewise, individuals with symptomatic VL have fewer regulatory cells when stimulated by SLA [CD4/CD25 (p = 0.0022) and CD4/FOXP3 (p = 0.0016)] and in the ex-vivo group (p = 0.0017). Finally, DNA isolated from recovered VL contained Leishmania DNA, supporting the hypothesis of non-sterile clinical cure for Leishmania infection. Recovered VL, even 10 years after treatment have high levels of memory cells, which may be due to the presence of stimulation, either by reexposure to Leishmania or non-sterile cure === A Leishmaniose visceral (LV) nas Am?ricas ? uma doen?a causada pela esp?cie Leishmania infantum chagasi (L.i.chagasi). A forma cl?nica evolutiva p?s-infec??o depende da resposta imune do hospedeiro vertebrado, que ? geneticamente mediada. Este estudo teve como objetivo avaliar a resposta imune de indiv?duos residentes em ?rea end?mica para LV no estado do Rio Grande do Norte, considerando indiv?duos com LV em tratamento (n=9), indiv?duos curados de LV < 1 ano (n=10) e > 10 anos p?s-tratamento (n=9), indiv?duos residentes em ?reas end?micas (n=7) aparentemente n?o infectados, indiv?duos que perderam a resposta DTH (n=6) e indiv?duos assintom?ticos para LV (n=9). C?lulas de sangue perif?rico foram avaliadas em presen?a e na aus?ncia de ant?genos sol?veis de Leishmania (SLA) e ex-vivo, para determina??o da ativa??o, da presen?a de c?lulas regulat?rias e de c?lulas de mem?ria. A parasitemia e anticorpo anti-Leishmania foram determinadas, respectivamente, por qPCR e ELISA. C?lulas oriundas de indiv?duos com LV em tratamento apresentaram menor ativa??o celular p?s-est?mulo com SLA para os marcadores CD4/CD69, CD8/CD69 e para CD8/CD25 quando comparado com LV p?s-tratamento (p<0,001). Indiv?duos aparentemente n?o infectados apresentam maior ativa??o celular que LV sintom?tico (p<0.001), com exce??o do marcador CD8/CD25 (p=0,6662). Por outro lado, na condi??o ex-vivo, diferen?as significativas foram observadas para CD4/CD69, CD8/CD69 e CD8/CD25 devido a uma maior ativa??o celular presente em c?lulas de indiv?duos LV sintom?ticos (p<0,001). Indiv?duos LV sintom?ticos, ex vivo, apresentam um menor percentual de c?lulas de mem?ria (CD4/CD45RO CD8/CD45RO) do que indiv?duos com LV p?stratamento ou controles (p=<0.01). Da mesma forma, indiv?duos com LV sintom?ticos apresentam uma menor quantidade de c?lulas regulat?rias quando estimuladas por SLA [CD4/CD25 (p= 0,0022) e CD4/FOXP3 (p= 0,0016)] e na condi??o ex-vivo (p=0.0017). Finalmente, pacientes com LV clinicamente recuperados permaneceram com parasitemia, determinado por qPCR, dando suporte ? hip?tese de cura cl?nica n?o est?ril para infec??o por Leishmania. Pacientes com LV recuperado, mesmo 10 anos p?s-tratamento mant?m n?veis elevados de c?lulas de mem?ria, que pode ser devido ? presen?a de ant?genos de Leishmania, seja devido ? re-exposi??o ? Leishmania ou por uma prov?vel cura n?o est?ril